» Articles » PMID: 8620471

Human Renal Cell Carcinogenesis is Accompanied by a Coordinate Loss of the Tissue Specific Transcription Factors HNF4 Alpha and HNF1 Alpha

Overview
Journal Cancer Lett
Specialty Oncology
Date 1996 Mar 29
PMID 8620471
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Human renal cell carcinogenesis is usually accompanied by dedifferentiation processes including the loss of expression of tissue specifically expressed genes. Based on the hypothesis that these dedifferentiation processes might be attributed to a functional change in tissue specific transcription factors, we have analyzed the expression and function of the tissue specific transcription factor HNF4 alpha in human renal cell carcinomas. By Western blot analysis and gel retardation assay using HNF4 alpha specific antibodies, we observed that in most cases the amount as well as the binding activity of HNF4 is reduced in the tumor samples compared to the corresponding normal tissues. Furthermore, we found a clear correlation between the HNF4 alpha binding activity and the amount of another transcription factor (HNF1 alpha), which is thought to be transcriptionally activated by HNF4 alpha. We therefore speculate that disruption of the HNF4 alpha/HNF1 alpha pathway of kidney specific gene expression might be an important molecular mechanism in renal cell carcinogenesis.

Citing Articles

Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver.

Teeli A, Luczynska K, Haque E, Gayas M, Winiarczyk D, Taniguchi H Cancers (Basel). 2021; 13(21).

PMID: 34771521 PMC: 8582545. DOI: 10.3390/cancers13215357.


Hepatocyte nuclear factor 4α and cancer-related cell signaling pathways: a promising insight into cancer treatment.

Lv D, Zhou L, Tang H Exp Mol Med. 2021; 53(1):8-18.

PMID: 33462379 PMC: 8080681. DOI: 10.1038/s12276-020-00551-1.


Molecular Dynamics Simulations Predict That rSNP Located in the Gene Promotor Region Linked with MODY3 and Hepatocellular Carcinoma Promotes Stronger Binding of the HNF‑4α Transcription Factor.

Spaninger E, Potocnik U, Bren U Biomolecules. 2020; 10(12).

PMID: 33371430 PMC: 7767403. DOI: 10.3390/biom10121700.


Treatment strategy for papillary renal cell carcinoma type 2: a case series of seven patients treated based on next generation sequencing data.

Kim J, Jeong H, Heo D, Keam B, Moon K, Kwak C Ann Transl Med. 2020; 8(21):1389.

PMID: 33313134 PMC: 7723617. DOI: 10.21037/atm-20-3466.


ABAT and ALDH6A1, regulated by transcription factor HNF4A, suppress tumorigenic capability in clear cell renal cell carcinoma.

Lu J, Chen Z, Zhao H, Dong H, Zhu L, Zhang Y J Transl Med. 2020; 18(1):101.

PMID: 32093682 PMC: 7038561. DOI: 10.1186/s12967-020-02268-1.